Last updated: May 19, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Joint Injuries
Treatment
Botulinum toxin type A
Clinical Study ID
NCT05863286
11 12 22
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients with TMJ habitual or recurrent dislocation
- Age ≥ 18 years
- The willingness of the patient to receive relative painful injections and to followinstructions
Exclusion
Exclusion Criteria:
- Patients with neurogenic cause of TMJ Hypermobility.
- Drug-induced TMJ Hypermobility
Study Design
Total Participants: 28
Treatment Group(s): 1
Primary Treatment: Botulinum toxin type A
Phase:
Study Start date:
December 30, 2022
Estimated Completion Date:
March 31, 2024
Study Description
Connect with a study center
Faculty of Dentistry, Cairo university
Cairo, Elmanial, Cairo 12613
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.